Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

People with alopecia areata often have thyroid autoimmunity.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

Proper diagnosis and treatment of childhood hair loss require distinguishing between alopecia and trichotillomania.

Smartwatch light therapy may help regrow hair in alopecia areata.

SASH1 gene mutations are linked to various inherited skin pigmentation disorders.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Cannabis might help hair regrowth in alopecia areata.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Alopecia areata is an autoimmune condition causing patchy hair loss, with treatments focusing on immune system regulation and hair regrowth.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Topical minoxidil did not significantly regrow hair in alopecia areata patients after 3 months.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

Eyelash regrowth occurred after eyelid surgery in a man with severe hair loss.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.